SCHEMBL2801027

SCHEMBL2801027

Cc1ccccc1C1CCN(C(=O)c2cnc3c(C(=O)NS(C)(=O)=O)cnn3c2NCc2ccccc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 1/20 0.40
AXL P30530 1/20 0.39
FLT3 P36888 1/20 0.39
TYRO3 Q06418 1/20 0.39
MERTK Q12866 1/20 0.39
MAPT P10636 3/20 0.38
ALDH1A1 P00352 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
LMNA P02545 1/20 0.37
SCN7A Q01118 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTR2B P41595 1/20 0.37
MAPK14 Q16539 1/20 0.37
TACR1 P25103 1/20 0.37
THRB P10828 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TP53 P04637 3/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2800914 0.92 RBP4 (0.41) RBP4AXLFLT3TYRO3MERTK
SCHEMBL2800990 0.91 AXL (0.42) AXLFLT3TYRO3MERTKMAPT
SCHEMBL2799687 0.90 STAT6 (0.40) RBP4AXLFLT3TYRO3MERTK
SCHEMBL2800606 0.90 NPSR1 (0.49) RBP4MAPTALDH1A1NPSR1SCN7A
SCHEMBL2802391 0.89 SMN1; SMN2 (0.41) AXLFLT3TYRO3MERTKMAPT
SCHEMBL2798553 0.88 THRB (0.37) RBP4AXLFLT3TYRO3MERTK
SCHEMBL2803544 0.87 TPSAB1 (0.40) AXLFLT3TYRO3MERTKMAPT
SCHEMBL2801428 0.87 ALDH1A1 (0.39) RBP4AXLFLT3TYRO3MERTK
SCHEMBL2800864 0.87 CCR1 (0.42) THRBSMN1; SMN2TP53
SCHEMBL2802693 0.87 TP53 (0.41) RBP4MAPTALDH1A1LMNASCN7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 RBP4 92/4885AXL 4690/4885FLT3 4427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.